Highlights gastrointestinal cancer & comment on ESMO guidelines in metastatic colorectal cancer

Dr. Andreas Wicki, Oberarzt Onkologie, Universitätsspital Basel:

SLIDES ESMO GUIDELINES
   

Lung cancer: Renowned experts from Switzerland and Austria are talking about their main takeaways from this year’s ESMO meeting

OA Dr. Georg Pall, Abteilung für Hämatologie & Onkologie MedUni Innsbruck & Dr. Solange Peters, Departement of Oncology Centre Hospitalier Universitaire Vaudois (produced by medONLINE in cooperation with oncoletter.ch, more info@ Immuno-Oncology Info Center):

   

Dermatologic cancers: Renowned experts from Switzerland and Austria are talking about their main takeaways from this year’s ESMO meeting.

Prof. Dr. Christoph Höller, Dermato-onkologische Ambulanz Allgemeines Krankenhaus Wien & Dr. Simone Goldinger, Department of Dermatology and VenerologyUniversity Hospital of Zürich (produced by medONLINE in cooperation with oncoletter.ch, more info@ Immuno-Oncology Info Center):

   

Kidney cancer: Renowned experts from Switzerland and Austria are talking about their main takeaways from this year’s ESMO meeting

Prof. Dr. Manuela Schmidinger, Clinical Division of Oncology Medical University of Vienna & Dr. Richard Cathomas, Abteilung Onkologie und HämatologieKantonsspital Graubünden (produced by medONLINE in cooperation with oncoletter.ch, more info@ Immuno-Oncology Info Center):

   

Interview mit Dr. med. Marc Thill, Chefarzt Frauenklinik, AGAPLESION MARKUS KRANKENHAUS, Frankfurt am Main. Thema: Plan B Studiendaten und Chalit-Studie zum Einsatz des OncotypeDx Genexpressionstests.

Interview geführt von Renate Haidinger, Brustkrebs Deutschland:

   

Interview mit Dr. med. Marc Thill, Chefarzt Frauenklinik, AGAPLESION MARKUS KRANKENHAUS, Frankfurt am Main. Thema: Erste prospektive TAILORx Studiendaten zum Einsatz des OncotypeDx Genexpressionstests

Interview geführt von Renate Haidinger, Brustkrebs Deutschland: